imidazole has been researched along with allopurinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Niu, H; Wang, F; Wang, J; Wang, S; Wu, C; Zhang, T | 1 |
| Bao, Z; Dai, X; Duan, Y; Feng, Y; Gao, J; Lei, Y; Lin, F; Liu, D; Mao, Q; Mou, Y; Wang, S; Yang, Y; Zhang, B; Zhang, Y; Zhao, J | 1 |
2 other study(ies) available for imidazole and allopurinol
| Article | Year |
|---|---|
Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.
Topics: Animals; Carboxylic Acids; Cattle; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthine Oxidase | 2015 |
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme System; Drug Stability; Enzyme Inhibitors; Half-Life; Humans; Imidazoles; Mice; Microsomes, Liver; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Structure-Activity Relationship; Ticagrelor; Xanthine Oxidase | 2020 |